GSK — GLAXOSMITHKLINE PLC

Ownership history in Squarepoint Ops LLC  ·  36 quarters on record

This page tracks every 13F SEC filing in which Squarepoint Ops LLC reported a position in GLAXOSMITHKLINE PLC (GSK). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.05% (2022 Q3)
Avg. % of fund
0.01%
First filed
2019 Q1
Last filed
2025 Q4
Quarters held
36
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 76,816 -56,184 -42.2% 0.00% $3.8M $48.65
2025 Q4 ADDED 133,000 +65,712 +97.7% 0.01% $6.5M $48.65
2025 Q3 ADDED 67,288 +16,288 +31.9% 0.00% $2.9M $42.44
2025 Q3 ADDED 51,000 +42,700 +514.5% 0.00% $2.2M $42.44
32 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    GSK price (monthly, adj. close)

Other funds also holding GSK

As of 2025 Q4 — sorted by position size

Eversept Partners, LP 3Y 7Y 6.62% Mondrian Investment Partners LTD 3Y 7Y 4.7% EQUITY INVESTMENT CORP 3Y 7Y 4.07% Callodine Capital Management, LP 3Y 7Y 3.96% Hillman Capital Management, Inc. 3Y 7Y 3.53% KEATING INVESTMENT COUNSELORS INC 3Y 7Y 2.45% MILLER HOWARD INVESTMENTS INC /NY 3Y 7Y 2.43% Clean Yield Group 3Y 7Y 2.2% NIA IMPACT ADVISORS, LLC 3Y 2.08% Altrius Capital Management Inc 3Y 2.05%
← Back to Squarepoint Ops LLC Holdings